Solmax

Quick links to important sections

Solmax

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Solmax

Quick Facts

Property Description
Active ingredient Carbocysteine (S-Carboxymethyl-L-cysteine)
Form Oral solution, Syrup, or Capsules
Pharmacological class Mucoactive agent, Mucolytic
Common use Facilitating the clearance of thick airway secretions
Origin Semi-synthetic (L-cysteine derivative)

What Type of Medicine is Solmax and What is its Active Ingredient?

The medicine Solmax is a pharmaceutical preparation classified as a mucoactive agent, specifically designated as a mucolytic agent. The active ingredient is Carbocysteine, which is chemically known as S-Carboxymethyl-L-cysteine. This core compound is systematically recognized as WHO ATC code R05CB03. Carbocysteine is a semi-synthetic derivative, having been derived from the naturally occurring amino acid L-cysteine. As a single-ingredient product, its function is distinctly focused on chemically modifying the physical properties of mucus, which is the primary characteristic that defines its pharmacological class.

What Forms Does Solmax Come In, and What is its General Purpose?

Solmax is intended for oral administration and is typically available in several dosage forms, including a liquid oral solution or syrup, as well as solid capsules. The general purpose of this preparation is to assist in the management of respiratory tract disorders associated with the production of excessive viscous mucus. The role of Carbocysteine involves improving the transport and function of the mucus layer. The medicine's physiological action is to reduce the stickiness and density of the phlegm, promoting the normalization of mucus hyperviscosity, which subsequently supports the easier expulsion of thick airway secretions.

What side effects are possible with Solmax?

Possible Side Effects and Safety Information

The safety profile of Solmax (Carbocysteine) is officially defined by adverse reactions categorized by frequency and the body systems they affect, as documented in governmental regulatory sources. The most frequently documented issues primarily involve the gastrointestinal system and the skin.

Adverse Reaction Categories

Classification Examples of Reactions Affected Systems
Common Diarrhoea, Nausea, Vomiting Gastrointestinal
Rare Anaphylactic reactions (severe allergy) Immune System
Frequency Not Known Gastrointestinal bleeding, Severe Cutaneous Adverse Reactions (SCARs), Epigastric discomfort Gastrointestinal, Skin

Adverse effects listed in official documents also include neurological disorders such as headache and dizziness, and isolated reports of hepatobiliary disorders like liver dysfunction.

Serious Reactions and Safety Constraints

The official labeling details the potential for rare but serious adverse reactions, notably Severe Cutaneous Adverse Reactions (SCARs), including Stevens-Johnson Syndrome, and systemic events like Anaphylactic Shock. The regulatory documents state that the medication must be discontinued immediately if signs of gastrointestinal bleeding or severe skin reactions occur.

Safety is also defined by explicit constraints on use. Solmax is contraindicated in patients with active peptic ulceration and in children under 2 years of age due to the reported risk of acute respiratory distress in this young population. Caution is also advised for older adults and individuals with a history of gastroduodenal ulcers.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory profile for an overdose of Solmax (Carbocysteine) is defined primarily by its effects on the Gastrointestinal (GI) system. The information below is strictly based on authoritative government regulatory documents.

Documented Overdose Presentations

Acute ingestion of an amount significantly higher than the recommended dose is most commonly associated with gastrointestinal disturbance. Officially documented symptoms include nausea, vomiting, diarrhea, epigastric discomfort, and abdominal pain. While these manifestations are typically transient, the potential for a more serious outcome such as gastrointestinal bleeding is acknowledged in regulatory documents and warrants caution.

Mandated Emergency Action

Immediate medical attention is required following a suspected overdose. Regulatory guidance mandates that if a dose significantly exceeds the maximum recommended amount (e.g., four to five times the normal therapeutic dose), patients must contact a doctor or poison control center right away or seek immediate medical attention at the nearest hospital. This requirement is in place to ensure proper assessment of the severity and management of potential complications.

Overdose Management

Management of a Carbocysteine overdose is described as symptomatic and supportive. Regulatory information explicitly states that no specific antidote is known for this compound. Procedural measures such as gastric lavage and hospital observation may be considered as part of the management strategy following excessive ingestion.

Therapeutic Uses of Solmax

Solmax is applied across therapeutic domains where additional symptomatic support is needed, primarily focusing on pain, inflammation, and fever. Medications of this type are commonly used to help with managing these manifestations. The medication is relevant in clinical settings marked by heightened discomfort and is considered applicable across conditions presenting with acute episodes or recurrent manifestations.

It is commonly used to help with symptoms related to physical discomfort, systemic imbalance (fever), and inflammatory states. Solmax may be part of symptomatic management for headaches, muscle aches, menstrual discomfort, and pain associated with minor injuries.

“Solmax may help patients cope more steadily with symptom fluctuations during periods of heightened symptoms.”

When supportive symptom management is appropriate, Solmax may assist with supporting functional stability by managing symptoms that interfere with daily comfort. By easing challenging manifestations, it contributes to easing the overall symptom load and supports general comfort.


Quick Fact: Assistance with Acute Discomfort Solmax is often used during phases when symptoms become more noticeable, helping to manage the intensity of discomfort from acute episodes.


Eligibility and Restrictions for Use

Who Can and Cannot Use Solmax?

The population eligibility for Solmax (Carbocysteine) is strictly defined by regulatory labeling based on age, pre-existing health conditions, and specific physiological states.

Absolute Contraindications

Solmax must not be used by individuals who have a known hypersensitivity to Carbocysteine or its excipients. It is also strictly contraindicated in patients with currently active peptic ulceration (in the stomach or gut). Age restrictions formally prohibit use in children less than two years of age.

Restricted and Not Recommended Use

Use of Solmax is not recommended for women who are pregnant, particularly during the first trimester, or for those who are breastfeeding. Caution is recommended when prescribing the medicine to elderly patients and to individuals with a history of gastro-duodenal ulcers. Additionally, certain formulations are prohibited in patients with hereditary metabolic disorders such as galactose intolerance due to specific excipients.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documentation on Solmax (Carbocysteine) interactions is primarily defined by risks stemming from pharmacodynamic effects and additive adverse effects, with a noted absence of documented pharmacokinetic interactions.


Pharmacodynamic Restrictions

Classification Interacting Substance/Class Restriction Type
Contraindicated Combination Antitussive medicinal products Co-administration is considered irrational due to opposing physiological effects on airway secretions.
Contraindicated Combination Medicinal products that dry respiratory secretions (e.g., Anticholinergics) Co-administration is considered irrational as these agents counteract the primary fluidifying action.

Adverse Effect Reinforcement and Metabolism

Caution is required when Solmax is co-administered with medicines known to increase the risk of gastrointestinal bleeding or ulcers, as this constitutes an additive adverse effect risk. Substances cited as examples include Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, and Antiplatelet medicines.

Official labeling generally indicates an absence of documented pharmacokinetic interactions, such as those mediated by common CYP enzymes or drug transporters. Furthermore, regulatory sources note a lack of sufficient information to confirm the safety of combining Carbocysteine with herbal remedies or complementary medicines.

Mechanism of Action

Muco-Regulation: Normalizing Mucus Quality

Solmax (Carbocysteine) acts as a muco-regulatory agent by directly modulating the activity of enzymes, such as Sialyltransferase and Fucosyltransferase, within the airway's Goblet cells. This modulation shifts the balance of mucin production toward less viscous, more fluid secretions, which contributes to modulating the physical properties of the mucus layer.

️ Targeting Airway Inflammation at the Cellular Level

The drug exerts a secondary mechanism by acting as an antioxidant, scavenging Reactive Oxygen Species (ROS), and suppressing key inflammatory signaling pathways, including the Nuclear Factor kappa-light-chain-enhancer of activated B cells (NF-κB) pathway. This interference reduces the cellular production of pro-inflammatory mediators and modulates the structure and function of the epithelial lining.

Influencing Mucociliary Transport Dynamics

The combined effect of reducing mucus viscosity and modulating inflammation influences the function of the Mucociliary Apparatus. The mechanism alters the viscosity and elasticity of secretions, which subsequently modifies the dynamics of ciliary transport of the airway fluid layer.

Dosage and Administration Information

How to Use Solmax — Administration Guidelines

This guide outlines the steps for taking Solmax. Adherence to these instructions is intended for correct use.


Administration Details

Administration Scope Requirement
Route of Administration Oral
Dosing Schedule Take one 100 mg tablet once daily.
Timing in Relation to Meals May be taken with or without food.
Age-Group Rules Approved for use in adults (18 years and older). Pediatric use is not recommended.
Preparation Requirement Swallow the tablet whole with a full glass of water. Do not crush, chew, or divide the tablet.

Procedural Steps

The following sequence is the protocol for taking the medicine:

  • Retrieve a single Solmax 100 mg tablet.
  • Swallow the tablet whole with a full glass of water.
  • Maintain a 24-hour interval between doses.

Missed Dose Instructions

If you miss a scheduled dose of Solmax, take the dose as soon as you remember. However, if it is almost time for the next scheduled dose, skip the missed dose entirely and resume your regular daily schedule. Do not take two doses to compensate for the skipped one.

Recent Clinical Evidence

Solmax: Research Evidence Overview

Research into Solmax (Carbocysteine) primarily focuses on its evaluation in respiratory tract disorders associated with thick mucus. The evidence base relies on systematic reviews, meta-analyses, and Randomized Controlled Trials (RCTs).


Evidence for Chronic Obstructive Pulmonary Disease (COPD)

In adults with stable COPD, long-term RCTs and systematic reviews have primarily research examined outcomes related to the frequency and rate of acute exacerbations and the associated risk of hospitalization. Some long-term trials described patterns observed in the studies, including differences in the reported rate of acute exacerbations when compared to placebo, particularly in specific groups of patients. However, the findings were mixed when researchers measured changes in lung function parameters. The overall evidence is characterized as Moderate due to the consistency of some reported outcomes but variability in others.


Evidence for Chronic Bronchitis and Otitis Media

For chronic bronchitis, studies monitored patterns related to measured changes in the physical properties of sputum. The evidence for this condition is limited by the frequent co-analysis of data with COPD patients, making the isolation of research outcomes specific to chronic bronchitis challenging. Research was also evaluated in pediatric patients for Otitis Media with Effusion (OME), examining the resolution of fluid accumulation in the ear. The evidence for OME is generally considered Low to Moderate certainty, as findings were mixed across various analyses.


Research Uncertainty and Gaps

Evidence quality varies across studies, and the comparative evidence is lacking in some systematic reviews. Follow-up durations were limited in many studies, meaning long-term effects are not fully established beyond the specific study periods. Data for certain groups, such as pregnant or breastfeeding populations, remain insufficient, and results apply only to the populations studied.

Key Studies & References

  1. Effect of carbocisteine on patients with COPD: a systematic review and meta-analysis (2018)
  2. Pharmacological treatment of glue ear in children - Systematic Literature Review (2022)
  3. WHO ATC/DDD Index: R05CB03 Carbocisteine (General Classification)

Frequently Asked Questions (FAQ)

Common questions about Solmax (FAQ)

Q: What is the main reason doctors prescribe Solmax?

A: Regulatory documents state that Solmax is indicated as an add-on treatment for conditions affecting the respiratory tract where excessive, thick mucus is produced. This often includes chronic conditions like Chronic Obstructive Airways Disease (COPD).

Q: How quickly should Solmax start working?

A: Official pharmacokinetic data indicates that the active ingredient is quickly absorbed after being taken orally. Peak concentrations, meaning the highest amount in the bloodstream, are typically reached within one to two hours.

Q: Does Solmax interact with common over-the-counter pain relievers?

A: Official product information advises caution when using Solmax alongside other medicines that may increase the risk of bleeding in the stomach or gut, such as certain Non-Steroidal Anti-Inflammatory Drugs (NSAIDs). This risk is related to potential additive adverse effects.

Q: Is it safe to drink alcohol while using Solmax?

A: While regulatory labeling does not state a direct interaction with beverage alcohol, it does note that some liquid formulations contain ethanol. The labeling notes caution for specific high-risk groups, including patients with liver disease or a history of alcohol use.

Q: Does Solmax cause weight gain?

A: Weight gain is not listed as a documented adverse reaction or undesirable effect in the official regulatory product information. The most frequently documented side effects primarily involve the gastrointestinal system.

Q: Is Solmax approved for use during pregnancy?

A: Regulatory documents state there are no available data on the use of Solmax in pregnant women. Due to this lack of data, use during pregnancy is generally not recommended, particularly in the first trimester.

Q: Can older adults (seniors) use Solmax safely?

A: Regulatory precautions recommend caution for elderly patients. This is due to a potential increased risk of gastrointestinal bleeding, especially in those with a history of stomach or gut ulcers.

Q: Does Solmax interact with birth control pills?

A: Regulatory documentation generally indicates an absence of known pharmacokinetic interactions. These types of interactions often mediate how Solmax might affect other medications, such as birth control pills.

Q: Does Solmax affect blood sugar levels?

A: Official regulatory product documentation does not list effects on blood sugar levels or other related endocrine disorders as documented adverse reactions.

Q: What kind of studies support the use of Solmax?

A: The purpose and classification of Solmax are supported by studies that demonstrated the substance’s ability to modulate the physical properties of mucus. Research evidence is described as being of moderate to low certainty across different indications.

Q: Does Solmax have a risk of allergic reaction?

A: Yes, Solmax is strictly contraindicated for individuals who have a known hypersensitivity or allergy to the drug or its inactive components. Severe allergic reactions, known as anaphylactic reactions, are reported as an adverse effect in the official safety profile.

Q: Why do some people take Solmax for a long time?

A: Solmax is indicated for the management of chronic conditions, such as Chronic Obstructive Airways Disease. Since these conditions may require ongoing therapeutic management, the use of the drug may be extended over time as part of a patient's regimen.

Q: What is the average duration of treatment with Solmax?

A: Regulatory guidance on the recommended treatment duration can vary based on the specific condition being treated and the formulation used. Treatment may be for a short time or a longer period, depending on the patient's therapeutic plan.

Q: Why do some patients stop taking Solmax?

A: Official regulatory documents mandate that the medication must be discontinued immediately if the patient experiences signs of severe adverse events. These include documented events like gastrointestinal bleeding or severe skin reactions.

Q: Can Solmax cause skin sensitivity to the sun?

A: Photosensitivity, which is an increased sensitivity of the skin to sunlight, is not listed as a documented adverse reaction or undesirable effect in the official regulatory product documentation.

Q: What is the official classification of Solmax (e.g., controlled substance)?

A: Solmax (Carbocysteine) is classified pharmacologically as a Mucoactive agent, specifically a Mucolytic. It is not listed as a controlled substance in the official schedules of major global regulatory authorities.

Q: Are there different strengths of Solmax available?

A: Yes, official product information indicates that the active ingredient is available in different strengths and different forms, such as capsules and liquid solutions.

Q: Can I take Solmax if I'm breastfeeding?

A: Use in breastfeeding women is not recommended by regulatory authorities. This is because there are no available data to confirm whether the drug passes into human milk or what potential effects it might have on a breastfed infant.

Q: What is the 'half-life' of Solmax?

A: Official pharmacokinetic data indicates that the elimination half-life of the active ingredient, which measures how quickly the drug is processed and eliminated by the body, is approximately 1.3 to 2 hours.

Q: Does Solmax interact with herbal supplements like St. John's Wort?

A: Regulatory sources state there is a lack of sufficient information available to confirm the safety of combining Solmax with herbal remedies or other complementary medicines. Caution is advised due to this data gap.

Q: Is the dose of Solmax based on my weight?

A: The official dosing recommendations for adults are provided as a standard daily dosage. Weight-based administration is not indicated in the regulatory instructions for adult use.

Q: Are there specific times of day to take Solmax?

A: The official dosing schedule specifies the frequency of administration (e.g., once daily or in divided doses) but generally does not mandate a specific time of day for the medicine to be taken.

Q: Can Solmax cause mood changes or depression?

A: Official regulatory documents list adverse neurological disorders such as headache and dizziness. However, mood changes or depression are not listed as documented adverse reactions.

Q: Can I take Solmax if I have kidney problems?

A: Some regulatory product information lists severe impairment of kidney function as a contraindication for the use of Solmax, meaning the medicine should not be used in this situation.

Q: Can I use Solmax if I have liver disease?

A: Caution is advised for patients with liver disease. This is because some liquid formulations of the medicine contain excipients like ethanol (alcohol), which may pose an additional risk to this patient group.

Q: Is Solmax a preventative medication?

A: The therapeutic indications for Solmax state that it is used as an adjunctive therapy to assist with the symptoms of respiratory tract disorders. It is not indicated as a medication solely for the prevention of disease.

Q: Where can I find the official patient information leaflet for Solmax?

A: Official patient information leaflets and regulatory summaries are publicly available through the websites of national government regulatory bodies, such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA).

How should Solmax be stored and disposed of?

Storage and Environmental Conditions

Solmax (Carbocysteine) must be stored strictly according to the conditions defined in the official regulatory labeling to ensure stability. Capsule and syrup formulations are generally required to be stored below 30 C or below 25 C, depending on the specific product formulation. The medicine should be kept away from direct heat and light at all times.

Stability and Packaging Rules

To ensure the labeled shelf-life is maintained, the product must remain within its original carton or blister packaging. It is mandatory not to use the medicine after the expiry date (EXP) printed on the packaging, as this date refers to the final day of the stated month.

Disposal and Child Safety

Solmax must always be kept out of the sight and reach of children. Regarding disposal, regulatory labeling strictly mandates that unused or expired medicine must not be thrown away via wastewater or household waste. Patients should ask a pharmacist for the correct local method to safely discard the product, adhering to environmental protection guidelines.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Solmax found in:

A-Z Index: